Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit

27 May 2013 - 29 May 2013 - Shanghai, China



Bookmark and Share


The 6th International Bio-pharmaceutical Industrial Development Innovation Forum & The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit will be held on May.27th-29th, 2012 in Shanghai, which organized by SEBMC, supported by International Alliance of Innovation Drug Research and European Association for Bio-industries and Biotechnology Industry Organization, at that time, more than 400 multinational pharmaceutical company leaders, global top level drug & medicine scientist and experts who from USA, Europe, China and Asia will join in this Forum, it will concern Bio-pharmaceutical, new drug research, innovative drug R&D outsourcing, pharmaceutical clinical research, translational medicine and personalized treatment technology, the Forum focus on new anticancer drugs, cardiovascular drugs, anti-diabetic drugs, neurodegenerative drugs, anti-infective drugs and resistance to major diseases drug innovation and clinical applications, antibody humanized technology and pharmaceutical technology invention, tumor molecular targeted drug development and targeted therapy technology, monoclonal antibody drug development and cell line development technology, Clinical Oncology Translational Medicine and individualized treatment, the forum will also explore that the Asian Pharmaceutical face the challenges of global blockbuster stage bio-pharmaceutical patents expiring peak, how to search for the production line of potential new drug development in Asia, how to control control the the new drug R&D investment and seek a reasonable balance during Drug Listing! Bring new drug development to maximize profits, to accelerate the transformation of drug R&D from the laboratory to clinical application, to search for future Asian new drug R&D trend and innovative model of win-win cooperation, to inject change drivers positive energy for the fast-growing Asian and emerging market R & D, to decode the Asian innovative drugs and translational medicine revolution, promote Asian new drug development and clinical medicine innovation. At the same time, The 6th (2013) International Bio-pharmaceutical and Biochemistry Instrument (Shanghai) Exhibition will be also held together, This exhibition will display comprehensively the Asian and international cutting-edge biomedical technology, the innovative biological products, laboratory equipment, clinical treatment and diagnostic testing equipment, diagnostic reagents and biochemical analysis equipment and other innovative products, this forum will be the most forefront event in Asian Pharmaceutical .



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!